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ABSTRACT
This paper uses a mixed-method approach to study cloud computing implementation in emerging
biotech and pharmaceutical companies. The study investigated four small biotech and
pharmaceutical companies. The objective was to determine the positive and negative impacts of
cloud computing and the impact of such implementation – especially the business impacts in an
increasing global and competitive environment. The unique benefits, drawbacks, and various
drivers of cloud implementation in these companies were identified. The research techniques
were mixed qualitative methods that included action research, observations, and review of other
case studies. The research indicated that small biotech and pharmaceutical companies found
cloud computing to be very attractive albeit with some drawbacks. The paper provides a detailed
discussion of the rationale in opting for cloud implementation by the emerging life-sciences
companies; a comprehensive literature review of cloud implementation; the processes involved
during the planning and implementation stages. The paper concludes by providing detailed
recommendations on cloud implementation to organizations in the life-sciences domain.
INTRODUCTION
Life-sciences organizations such as bio-tech and pharmaceutical companies are natural
candidates for cloud-computing implementations. These companies, whether they are start-ups or
well established market players, are typically characterized by their intense research and
development (R&D) efforts that constantly generate massive volumes of data. The data emanate
from various phases that include the pre-clinical trials phase, clinical trials phase, drug approval
phase and finally the production, marketing and post-sales phases. At each phase, the large
volumes of data generated require to be analyzed, categorized and securely stored in accordance
with regulatory mandates and corporate directives. The data analysis and processing can be time
consuming, yet have to be accomplished expeditiously, given the intensely competitive global
environment under which these companies operate. The need for cost and time controls is
critical, as life-sciences companies need to adhere to increasingly aggressive development
timelines and comply with changing global regulations in a timely manner. The cost and security
requirements alone would deter most start-ups in the life-sciences.
Recent developments in cloud computing and cloud implementations offer the promise of
efficient and cost-effective data analysis and processing as well as multi-layered security and
controls to small biotech and pharmaceutical organizations that often cannot achieve these on
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their own. Given the constraints that small life-sciences companies face, and the promise that
cloud computing offers, it is useful to study the experiences of small to medium sized lifesciences companies that have moved to implement cloud-based computing. This paper discusses
the results of a study of cloud computing implementation in the context of four emerging lifesciences companies in North America. The study identifies the common themes shared by the
companies in their move towards cloud implementation. The focus is on the processes involved,
perceptions of the various stakeholders, benefits and challenges, and lessons learned.
Our primary focus is the experiential aspects of cloud implementation and the realistic
challenges that such implementations pose on small and emerging life sciences companies. As a
result of our study we are able to provide a comprehensive set of recommendations pertaining to
cloud implementation that would be useful to other similar small and medium life-sciences (and
possibly other) companies. The study used a mixed-method approach, employing library and
media research, public and confidential documents, interviews, surveys and case-studies. We
believe that our results and recommendations are a valuable addition to the available literature in
the field, in addition to serving as a comprehensive guide to potential cloud implementers.
This paper is organized as follows. In the section that follows immediately, we provide a
background on cloud computing and various cloud computing models. Following that, we
provide a detailed literature review and show how our work differs from past work in this area.
We then list the questions that we hope to provide answers for. We follow that with a discussion
on the methodology used in our study along with our justification and the data collection
methods we employ. This is followed by a detailed analysis of the data collected. The data
analysis includes cases of representative companies that were studied. Finally, we provide a
comprehensive list of recommendations for small life-sciences companies that intend to move
towards cloud computing. Following that we offer our conclusions and propose some future
work in this area.
BACKGROUND
Despite the present-day hype that surrounds it, the concept of cloud computing mystifies many
organizations – especially those dealing with the deluge of data being generated, such as small
life-sciences companies. Multiple terms are often used to describe cloud computing, e.g. grid,
distributed, on-demand, cluster, utility, virtualization, and software-as-a-service. The U.S.
National Institute of Standards and Technology (NIST) provides a “Working Definition of Cloud
Computing” in the document NIST 800-145. NIST’s definition describes five crucial
characteristics of cloud computing (i.e. broad network access, rapid elasticity, measured service,
on-demand self-service, and resource pooling), three cloud service models (i.e. Software as a
Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS)), and four
cloud deployment models (i.e. public, private, hybrid, and community). Simply stated, cloud
computing refers to end-users connecting, on demand, with applications or services running on
shared servers, often hosted and virtualized, rather than traditional, in-house, dedicated servers.
Thus cloud computing dramatically differs from the decades-old client-server computing model
where applications were assigned to specific hardware, often residing on-location in data centers.
On-demand cloud computing also empowers its end-users by allowing them to use their choice
of Internet-connected devices, anywhere or at any time (Knorr & Gruman, 2009).
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An important factor in favor of cloud computing is its low cost, pay-as-you-grow business
model. This model puts sophisticated and complex computing capabilities within reach of even
small companies, thereby enabling these companies to use and transform information technology
into an engine that drives business (Cognizant, 2010). Companies could use cloud computing to
economically scale their businesses as needed, while rapidly completing complex research-tomarket tasks they simply could not accomplish on their own (Bowers, 2011). Thus cloud
computing promises cost-savings, increased agility, and the type of scalability that responds to
the rapid changes in both technology and business needs.
REVIEW OF LITERATURE
A review of research on cloud computing in life sciences reveals that this is an active area of
research. The prior research has generally focused on the following areas:






Cost reduction and increased speed: According to Proffitt (2009), early adopters of
cloud computing such as Pfizer, Johnson & Johnson, and Eli Lily all used Amazon
Web Services (AWS) and Amazon EC2 (Elastic Compute Cloud).
These
pharmaceutical companies were able to perform R&D using the cloud, and process
proteomics, bioinformatics, statistics and adaptive trial design more rapidly with
predictable time and costs. BioTeam co-founder and technology director Chris
Dagdigian noted that Amazon’s cloud computing rates started at 10 cents per hour,
and calculated that a traditional 100 CPU-hour research problem could be solved
using EC2 in 1 hour for $40 (Davies, 2009). Heritage (2012) argued that small
pharma and biotech companies which do not have the resources to support a large
informatics infrastructure, could use SaaS based informatics that save time, costs,
which are more effective with better collaborative workflows. Another study showed
how BT in England partnered with Accelrys to create a life sciences research and
development cloud, or On Demand Compute service. The partnership helped
scientists working in the pharmaceutical and biotech industries reduce the costs
associated with R&D when bringing new drugs to market (Nguyen, 2012).
Effects of enhanced connectivity: Effective connectivity is a major factor in lifesciences research and development. Kubick (2011) argued that cloud computing,
using a solitary Internet connection, could reduce the effort of individually integrating
each research system at various locations yet provide availability to all. Bowers
(2011) suggested that cloud service providers (CSPs) could provide SMB lifesciences organizations with “best practices” such as comprehensive data protection,
24x7 disaster recovery, multi-site replication, real-time monitoring, and state-of-theart emergency response systems – services they generally could not afford.
Scalability and performance: According to May (2010), most life science
companies lack the necessary computing infrastructure required to analyze and store
their research data. In order to increase their computational power, many life science
researchers are searching beyond their own organizations and turning to decentralized
systems, like supercomputers or grids of many smaller computers working together.
Along the same lines, Taylor (2010) noted that bioinformatics researchers, using ultra
large data sets, achieved better performance with respect to management of failures,
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data analysis, and computational jobs using cloud based systems. Afgan et al. (2010)
illustrated how to deploy a compute cluster using the Amazon EC2 cloud and Galaxy
CloudMan. Their system was simple to use and enabled small groups of researchers
to deploy heavy computational resources without requiring support from skilled
bioinformatics personnel. Barbadora (2012) noted that an increasing number of SMB
life sciences companies are choosing cloud-based CRMs that give them enterpriseclass performance within a reasonably priced model. These systems historically are
cost-prohibitive for most small life sciences companies because traditional in-house
CRM applications, ongoing maintenance, and upgrade costs are normally beyond
their budgets.
Collaborative drug discovery and data analysis: CSPs are now providing cloudbased drug discovery software platforms that increase the power of collaboration.
These private, secure cloud architectures create a barrier-free virtual world that
permits researchers in remote areas, sometimes with few technological resources, to
fully participate in research projects (McCarthy, 2012). Vandeweyer, Reyniers,
Wuyts, Rooms, and Kooy (2011) discussed on the collaborative advantages of cloud
computing and noted that open-source web based platforms such as CNV-WebStore
are being used in clinical practice by both lab technicians and clinicians to compare
results against clinical information without producing overwhelming amounts of data
(Vandeweyer et al, 2011). Chidambaram studied how a small life sciences company
can effectively manage their collaborations and document sharing, CRM, and ERP all
in the cloud (Chidambaram, 2011).
Cloud database technologies and their efficacy: Taylor (2010) noted that new open
source database technologies such as Apache Hadoop, Hbase, and MapReduce are
cost-effective, reliable, scalable, and distributed. These technologies in the cloud
provide SMB life science companies with distributed processing of large data sets
across clusters of computers using a simple programming model (Taylor, 2010). Do,
Esteves, Karten, and Bier (Do et al, 2010) researched Booly, a similar cloud-based
relational database that runs on multiple load balanced servers and can easily be
accessed through a graphical user interface using a web browser. They noted that
Booly is a comprehensive platform for the creation, storage, and integration of
biological databases that can assist researchers in developing novel discoveries in the
laboratory. Qiu et al. maintained a hybrid cloud that utilized MapReduce combined
with Message-Passing Interface (MPI) standard, for programming parallel computers
– technology that offers an appealing production environment for life sciences
applications. They also used three cloud-based computational infrastructures in their
study (Azure, Amazon and FutureGrid) and showed how life science organizations
with few resources could successfully create this environment (Qiu et al., 2010).
Cloud security issues: Sansom (2010) argued that while cloud computing may offer
compelling solutions for small companies that struggle with very large data sets, only
“precompetitive or non-confidential” data would be used in the cloud due to security
issues. However, CSPs are currently helping small life science start-up companies
manage their public and private clouds using Amazon and Google. Kubick (2011)
noted the security and loss of control issues resulting from cloud computing but
argued that in most cases a CSP provides much higher degrees of disaster recovery
and auditable security than most internal IT departments. Bowers (2011) expanded on
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these ideas and suggested data security in the cloud must be strong, extensive, and
dependable, and adhere to regulatory requirements, and went on to suggest a variety
of codes, regulations and certifications that pertained to life-sciences companies. A
2008 study by Gartner Research (Gartner Research, 2008) suggested that security
delivered as a cloud-based service, would more than triple in life science
organizations by 2013.
Regulatory issues: Besides cloud security, another concern of many life science
organizations is the typical regulatory concerns. Kubick (2011) noted that CSPs
should comply with Health Insurance Portability and Accountability Act (HIPAA),
Good Clinical Practice (GCP) standards, and have their cloud services regularly
audited. However he also suggested that regulatory agencies and their lack of
definitive regulatory positions can negatively influence attitudes regarding cloud
adoption, thus making small life science companies wary of cloud computing. Gorban
(2012) maintained regulated environments that utilize cloud computing can manage
compliance with the use of strong controls and auditable documentation, thereby
mitigating associated risks.
Efficiency issues: Clinical trials at life science companies have become more global
and regulatory examination has continued to climb, making paper-based processes
even more difficult. Clinical trials, in particular, require the tracking of documents
being sent between multiple sites, sponsors, contract research organizations (CROs),
and stakeholders. To counter this, Shurell (2010) argued that by using a SaaS-based
solution in the cloud, electronic documents can be securely tracked globally, which
can accelerate contract negotiations, patient recruitment, protocol design, clinical
trials, and other activities of pharmaceutical companies. Bowers (2011) also cited
examples of life science organizations that use cloud computing in fundamental
research to speed up the development process. He noted that companies were able to
bring down fixed IT costs without undermining service levels, while significantly
expanding computing and storage capabilities.

The literature survey above shows that cloud computing is currently an active area of
research. Various research projects have addressed a variety of issues pertaining to cloud
computing, in various contexts. In summarizing the above, the following observations can be
made:
 A variety of new technologies (including several open source technologies) have
emerged over recent years that enable and enhance cloud computing
 Several large CSPs have emerged in recent years, providing a variety of cloud
computing services.
 SMB life science companies could experience remarkable economic advantages and
time-saving by migrating their computing to a cloud service provider.
 The process of implementing a cloud solution could take a much shorter time when
compared to traditional in-house solutions, without interrupting normal business.
 Cloud-based systems would require minimal in-house IT support, which liberates
infrastructure and resources for other activities.
 Cloud computing requires smaller upfront investment and provides predictable cost
management that is based on operating budgets instead of capital budgets, which is
particularly attractive to start-up companies.
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Established pharmaceutical and biotechnology companies have adopted IaaS and
PaaS for computationally heavy research such as molecular modeling, proteomics,
and bioinformatics. These companies thus had immediate access to on-demand
processing and storage services along with hosted environments for developing
custom applications.
These types of services are especially attractive to start-ups, considering they can
avoid capital investments and instead rent the computing infrastructure needed during
product development.
Cloud computing also reduces start-up times and can be made available much faster
than it takes to build infrastructure internally, without bureaucratic hurdles or delays.
Cloud computing enhances global collaborations at substantially low costs.
Cloud implementations should carefully consider the security and regulatory aspects
and implications while planning to move to the cloud.

Some of the literature also describes results accruing from cloud implementation. However, there
is not much in the above that studies describe the actual experience of cloud implementation in
small and medium sized life-sciences companies, and the perceptions, questions and strategic
decision-making that accompany such implementations. Nor does the literature discuss the
benefits and challenges that accrue from cloud implementation in small life-sciences companies.
Our study addresses this gap in the above literature.
As noted above, the main objective of our study was to examine the various aspects of cloud
computing implementation as it relates to emerging life-sciences companies. We hoped to
identify the unique benefits, drawbacks, and various drivers of cloud implementation in these
companies. Given this main objective, the study then looked at the following questions:
1. What were the perceived benefits in a company’s move towards cloud implementation?
2. What were the observed challenges in a company’s cloud implementation strategy?
3. What were the cloud implementation strategies used by the companies studied (including
models, vendors and applications)
4. What were the management and implementation issues associated with cloud
implementation (including change management, IT loss of control, avoiding vendor lockin)?
5. What was the security, legal and regulatory issues associated with cloud implementation?
6. How can the cloud implementations plan for future technology developments (e.g.
virtualization)?
7. What would be the recommendations to emerging life-sciences companies with regards
to cloud implementation?
METHODOLOGY
Our study primarily followed a mixed-methods approach using techniques such as first-hand
observations, interviews, case studies, and peer-reviewed published literature, augmented by
surveys. It was thought that the mixed-methods approach would garner multiple points of view
for comparative purposes. Bias was minimized during the analysis process through the use of
electronic data gathering and validated responses.
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Sample Population Selection
The population in this research was four emerging biotech and pharmaceutical companies, each
with less than 100 employees. Three of those are private companies and one is publicly listed,
with current market value of less than $25 per share. All four companies are considered SMB
life science companies with market capitalization of less than $100 million. All organizations
and participants utilized cloud computing prior to the beginning of this study, for periods ranging
from one to seven years. The sample population was chosen using purposeful sampling based on
the participant or stakeholder's experience. Prior permission was obtained whenever gathering
data within the organizations, and all participation was voluntary. Specific sample groups
included: managers and senior management - with an understanding of the strategic goals and
corporate business plan, technical staff - with an understanding of cloud mechanics, and cloud
end-users (also known as 'internal customers') within the organization. The sample population
consisted of 47 total participants within the four companies: 11 participants were managers or
senior managers, 17 participants were technical staff, and 19 participants were cloud end-users.
Data Collection
Qualitative data was collected through detailed interviews, as well as from internal documents,
trade journals, media reports and by deploying a survey. Long interviews1 were conducted on
selected representatives from the companies as mentioned above. Interviews were electronically
recorded and later transcribed, then given to participants for verification of content and meaning.
Validity was determined using interviewer corroboration and member check, or respondent
validation, by verifying the quality of the researcher's data and conclusions when compared with
the experiences of the research participants. Notes from first hand observations, case studies, and
peer-reviewed literature were captured electronically and verified by repetitive review and crossexamination. Additionally, a concept map was created, using Wordle.net, with the electronic data
that was collected from the various methods.
Survey data was collected electronically first-hand and remotely by using SurveyMonkey survey
software, one laptop, one iPhone, and one iPad. Ten survey questions (please see Appendix
Figure A-1) were designed to reveal the advantages and disadvantages of cloud computing and to
illicit clusters of opinions and overall themes from research participants. The questions were
posed to sample population participants electronically in survey form as well verbally during
structured interviews. The surveys allowed the researcher to reach a large majority of the sample
population, while the interviews were held independently with approximately 10 percent of the
sample population. Survey responses were given to respondents for verification of their accuracy.

1

A ‘long interview’ is ‘a sharply focused, rapid, highly intensive interview process that seeks to diminish
the indeterminacy and redundancy that attends more unstructured research processes. The long interview calls for
special kinds of preparation and structure, including the use of an open-ended questionnaire, so that the investigator
can maximize the value of the time spent with the respondent’ (McCracken 1998). The researchers felt that this type
of data collection method would provide a subject’s critical interpretation of an event or development as experienced
by him or her.
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ANALYSIS
To achieve the objectives of the study we needed analyze the data and identify themes that were
common to all of the companies studied, especially with respect to perceptions, questions and
strategic decision-making among the stakeholders. The various data types collected (text, audio,
images, survey, etc.) were input into the TAMS Analyzer, a computer-assisted qualitative data
analysis software (CAQDAS) system, which aided in coding and the identification of themes.
A meta-analysis was conducted from reading and reviewing research data, the literature review,
observations, notes, interviews, surveys, transcripts, case studies, and research documentation
provided by the participant companies. Obvious patterns that reflected the advantages and
disadvantages of cloud computing were gathered. The concept map was regularly updated,
which helped visually classify, code, and identify meaningful clusters. Through this exercise and
additional sorting and organizing, patterns and themes began to emerge.
These patterns and themes can be broadly categorized as benefits, challenges, and the associated
ramifications.
Benefits
Based on the data aggregated from the interviews and surveys, we identified several benefits, the
most significant of which (as noted by the participants) were reduced cost, the ability to avoid
future IT expenses. Other benefits listed were:








Improved scalability of IT resources – access to extensive file storage
Quick set-up, more flexible, 24x7 connectivity and management.
Enhanced security and privacy features.
Increased collaboration on drug discovery.
Availability of on-demand, redundant cloud databases.
Better life sciences efficiency and regulatory compliance.
The availability of multiple CSPs, thus providing more comparison and choices.

Overall, the participants were positive about cloud experience. The following case vignette of
one of the companies studied corroborates these positive aspects.
Vignette 1: Company A found its business development and strategic partnerships
suddenly required extensive file storage and file sharing. The company wanted extra
storage available for both internal users and third-party partners, regardless of
location or time of day. With limited resources and no full-time IT staff, the company
chose cloud file servers that were quickly setup and then managed 24x7 by cloud
service providers. The company easily added several terabytes of cloud storage for
secure file sharing and collaboration via Windows, Mac, and iOS/Android mobile
applications. The company found user management was simple and included auditable
privacy/authentication controls (AD/LDAP), file versioning, file locking (check in/check
out), and virtual dropbox (drag-n-drop) services. These cloud file servers included
redundant real-time data center mirrors that were SSAE 16 compliant colocation
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facilities and SAS70 Type II compliant data centers, with 99.999% up-time guarantees.
For less than $5 per user/per month the company's cloud file servers provided
enterprise class features with continuous 256-bit AES encryption (in transit and at rest),
and multi-level access controls that were HIPAA and Safe Harbor compliant. The
company found its initial file sharing experience so positive that it identified new uses
for its cloud storage. The company added real-time disaster recovery of its critical IT
systems, desktop, laptop, and mobile users. With persistent file versioning these new
backups complied with the company's data retention policy and permitted litigation
holds of off-site files in the event of future legal actions. Additionally the company's
project teams found cloud storage easier to collaborate with regardless of file size or
local of worldwide partners, and it provided limited risk of violating HIPAA
compliance. Overall the company's experience with cloud storage and cloud file
sharing was very positive.
Challenges
The biggest challenge noted by the participants was cloud security. Other challenges that were
explicitly mentioned or became apparent during the study were:







Maintaining Privacy and confidentiality of corporate data.
Loss of control within the IT function (e.g. managing multiple platforms and devices)
Maintaining reliability of key systems and availability of services or data.
Lack of organizational control over services or data.
Legal ramifications (government regulations, compliance and auditing)
Concerns over cloud vendor lock-in.

The existence of these challenges was corroborated by another illustrative case vignette:
Vignette 2: Almost every employee at Company B frequently used some type of mobile
device (smartphone or tablet) for both work-related and personal computing. All of
these devices connected to the company’s cloud environment. Managing or controlling
that process quickly became a challenge. Mistakes were made early on, ranging from
not researching (ahead of time) how workers could best use the devices, to
underestimating the costs and the additional security challenges mobile devices present.
The use of multiple devices rapidly changed what the company felt was the best practice
of its cloud infrastructure. As the company grew and the staff worked longer hours,
nights and weekends, personally owned BOYD (bring-your-own-device) mobile devices
quickly became a low-cost (owned by the employee) necessity that required the
organization to adapt. Initially the company did not grasp or plan for the full impact of
mobile cloud computing and soon became overwhelmed by its failure to adequately
manage and support mobile devices. BYOD also quickly exposed the company to a
major security issue as employees learned they could bypass security controls on their
company-owned device(s) via "jailbreak" (Apple iOS) or "root" (Google Android). This
process allowed users to run pirated applications on their mobile devices and to bypass
built-in security controls, in order to fully customize mobile devices more than device
manufacturers allow. These workarounds and loopholes also created data leakages and
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security holes that could be used by undesired spyware or malware to steal or corrupt
sensitive data. In addition, these created the possibility of sensitive corporate data
being transferred to unsecured personal devices without the ability to remote wipe the
hard drives if the mobile device was stolen. In order to mitigate these issues and
protect its cloud data the company was compelled to make several operational changes
(discussed in more detail later in the Recommendations section). The changes included:
(a) Developing a comprehensive mobile security plan after reassessing its overall
security policies and procedures, and (b) Investing in proper management tools i.e.,
deploying Mobile Device Management (MDM) system that secured, monitored, and
managed all mobile devices that connected to the Company's cloud resources. The
MDM also prevented jailbreaking devices and defined applications that were required,
permitted, or banned.
Ramifications
The most common ramifications felt by the companies pertained to managing system changes
security, regulatory compliance, legal compliance, as well as the emergence of threats such as
loss of IT control and vendor lock-in.
Managing System Changes
Participants acknowledged they depended on automatic change management with no additional
expenditures for future updates, in terms of software and hardware. Participants expressed
concerns about reliability in terms of changes made by CSPs and how these changes affected
their business needs and/or might negatively impact their production environments. Therefore
the companies required advance notice from CSPs prior to the application of software patches or
updates. They took efforts to have redundancies in place to ensure that risks from patches and
upgrades were minimal. Appropriate personnel (e.g. IT staff, scientists, and project management
staff) monitored, scheduled and approved changes made by the CSPs. Due to these change
management efforts, the entire process – from initial cloud deployment to on-going change
management proceeded with no significant issues in terms of down-time or additional costs. The
participants generally indicated that they had high-availability (HA) systems (Sommer, 2013).
Security Issues
Participants in this study cited, most often, confidentiality and security, and the associated
complexity, as the greatest concerns of cloud computing. However, security protection offered
by their cloud service providers (CSPs) was considered an advantage by most organizations that
utilized strong Service-Level Agreements (SLAs) and appropriate security controls. Most
organizations also viewed security controls in cloud computing as no different from security
controls in other IT environments. All organizations in this study mitigated risks by requiring
CSPs (or themselves) to use strong encryption and privately controlled encryption keys, both
during data transit and storage inside the cloud infrastructure. Participants frequently cited their
desire for enhanced security in the following areas: corporate data security, application security,
process security, infrastructure security, R&D security, and personnel security. A majority of
these companies also maintained they required comprehensive security standards be used by
their CSPs, such as: HIPAA, SAS70 Type II or SSAE 16, Safe Harbor Compliance, FIPS 200 /
SP 800-53, ISO 27001, ISO 27002, SOC 2 & 3, WebTrust and SysTrust, and Certificate of
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Cloud Security Knowledge (CCSK) (Sommer, 2013). A participant at a company stated that they
had strong controls in place and performed frequent audits based on industry security standards.
They also used a comprehensive framework provided by the Cloud Security Alliance that helped
them evaluate cloud computing risks and informed their security decisions.
Regulatory compliance
Organizations in this case study were required to comply with various regulatory agencies and
auditors both inside and outside the United States. Participants suggested that their use of cloud
computing provided them with regulatory proficiency that was compliant, scalable, and ondemand. One participant explained that every CSP that the company used complied with their
audit and compliance requirements. For example, the participant at the company indicated that
its compliance with HIPAA laws required that patient data be kept safe, and therefore the
company only used CSPs that provided HIPAA compliance. Participants also frequently noted
that their cloud-based systems had full disaster recovery capabilities and underwent frequent
audits. One major issue for some of these organizations was the U.S. Food and Drig
Administration’s (FDA) “21 CFR Part-11” compliance that requires regular validation of
systems hardware. These participants required that CSPs provide evidence of “21 CFR Part-11”
compliance, such as validated e-signatures, system controls, hardware/software version and
revision control, plus reporting and auditing abilities that verified record integrity and reliability.
Legal Ramifications
A majority of participants cited legal issues as a major concern of cloud computing. All
participant organizations required clear legal definitions in their CSP agreements on what
was/was not being provided by CSPs, ownership of information/system, as well as what should
happen in case a vendor filed for bankruptcy. A majority of organizations indicated that when
CSPs were clearly aware of the consequences for violating these policies, it motivated them to
successfully execute their agreements. Furthermore, these organizations avoided SLAs or
contracts that limited, ignored, or glossed over potential data loss, privacy, security and ediscovery issues. These organizations expected CSPs to assume responsibility and liability in
case of network outages and data loss (Sommer, 2013). One participant indicated that the
company had requested indemnification clauses in some of their service-level agreements that
penalized CSPs when agreements were violated. Additional legal concerns that require to be
specifically addressed with cloud-based implementations were related to laws such as: SarbanesOxley, the Gramm-Leach-Bliley Act, and the Patient Protection and Affordable Care Act.
Cloud Vendor Lock-in
Another major concern from a majority of organizations cited was their perceived inability to
move to another cloud offering or to another CSP. Few organizations had undergone significant
moves, therefore much of this fear was speculation. However, in order to alleviate this issue,
most organizations viewed data portability as a crucial aspect as it chose CSPs. Deployments
that utilized different cloud provider solutions, e.g. for disaster recovery or global presence, were
considered the best solutions in terms of portability and risk management (Sommer, 2013). As
these organizations grew and expanded to several disparate CSPs, with different infrastructures,
operational practices, and security expertise, they expected the levels of complexity would
inevitably increase. Organizations realized this requires a pervasive and highly trustworthy
method of securing organizational data as it is securely transported data to and from the cloud.
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Lack of IS Control
A majority of participants in this study indicated they believed their organizations lacked
complete control over their data, which they saw as an ongoing issue. Although most CSPs
used by participant organizations deployed fully automated management platforms that
maintained IT control and transparency, they could not provide specific instances where lack of
control resulted in negative outcomes since cloud adoption. Several participants described
experiences prior to cloud adoption when their in-house controls failed, mainly due to their small
staffs and inadequate support (Sommer, 2013). Participant from one company explained they
quickly overcame their hesitation and turned-over control to a CSP after their own in-house IT
systems failed. Overall lack of IS control became less of an issue as time passed and
organizations relied more heavily on the scalability and reliability of their CSP provided systems.
RECOMMENDATIONS
Throughout the lifespan of life science organizations – from start-up to R&D, from the preclinical phase to clinical trial work, and from drug approval to market – the massive volumes of
data constantly generated must be analyzed and securely stored in accordance with regulatory
agencies and corporate directives, all while improving cost and time efficiencies. Cloud
computing, when properly implemented, has the promise of adding multiple security layers and
controls that small biotech and pharmaceutical organizations often cannot accomplish with their
scarce resources.
Organizations can start by first introducing cloud computing into routine processes, without large
capital expenditures, and then increase usage as necessary. However, cloud implementation also
poses many challenges and concerns. Our comprehensive analysis above forms the basis for
certain specific recommendations that we feel are major concerns in cloud implementations,
especially in emerging life-sciences companies.
Cloud Security & Privacy
Cloud security and privacy in life-science organizations are one of the most critical
considerations when considering cloud implementation. These are complex issues, as evidenced
by their use of public, private, and hybrid cloud models and varied off-site infrastructure and
physical locations. Organizations concerned about overall cloud security can significantly
improve data protection and the associated infrastructure with proper planning, evaluation, and
monitoring of CSPs along with these key security elements:






Application Security: verify strong encryption and authentication controls are used.
Data Security: verify auditable security checks and best practice cryptography, that
prevent breaches, are used.
Infrastructure Security: verify redundancy of infrastructure and uninterruptible
service are tested and used.
Process Security: verify industry best practices are used, and managed by certified
security professionals.
Personnel Security: verify background checks and strong confidentiality agreements,
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with all personnel exposed to data, are used.
Product Development Security: verify secure development lifecycle processes are
used, that protect applications in production and in development (Cloud Security
Alliance, 2011).

Additionally, organizations should enhance their cloud security and privacy by implementing
2048-bit SSL certificates in SaaS systems. Organizations should add more comprehensive cloud
security guidelines to their enterprise architecture. The Cloud Security Alliance provides
security guidance in 14 domains that cover operation and governance of cloud services (Cloud
Security Alliance, 2011). These domains emphasize security and privacy in a multitenant
environment, for example:















Domain 1: Cloud Computing Architectural Framework
Domain 2: Governance and Enterprise Risk Management
Domain 3: Legal Issues: Contracts and Electronic Discovery
Domain 4: Compliance and Audit Management
Domain 5: Information Management and Data Security
Domain 6: Interoperability and Portability
Domain 7: Traditional Security, Business Continuity, and Disaster Recovery
Domain 8: Data Center Operations
Domain 9: Incident Response
Domain 10: Application Security
Domain 11: Encryption and Key Management
Domain 12: Identity, Entitlement, and Access Management
Domain 13: Virtualization
Domain 14: Security as a Service

Identity Management
An important part of cloud computing is the process of managing users, controlling their access
to applications and services, and the authentication of users in a Web Services world. For years
two of the most broadly adopted authentication and authorization standards have been Kerberos
and Security Assertion Markup Language (SAML). However, cloud service providers are
beginning to embrace newer standards such as OAuth 2.0, OpenID Connect, and Simple Cloud
Identity Management (SCIM) in order to more easily exchange authentication information
between multiple cloud providers and companies from web, mobile and desktop applications.
According to the Cloud Security Alliance, SCIM is a newly emerging standard that makes the
management of identities inexpensive, with simpler and faster implementation, while making it
easy for organizations to migrate user identities into and out of the cloud. Furthermore SCIM is
considered cloud-friendly because its RESTful API is supported by many cloud service providers
and it works with existing authentication protocols like OAuth 2.0 and OpenID connect (Cloud
Security Alliance, 2011). According to analyst Sean Deuby, OAuth 2.0 and OpenID Connect are
two newer identity frameworks that support the next generation of web single sign-on (Deuby,
2013). Case Vignette 2 in the Analysis section showcased the challenges brought out by a
multiplicity of devices. The main issue is authentication and authorization. Organizations
considering cloud adoption should evaluate these newer identity management frameworks and
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seek cloud service providers that support them, not only for easier interoperability with other
cloud service providers, but for use with hybrid cloud environments, partners, and future growth
as small companies progress into enterprises. The OpenID Connect Protocol Suite is illustrated
in the Appendix A-2.
Mobile Security
Case Vignette 2 in the Analysis section also brought out the reality of BYOD in organizations.
Cloud computing and the popularity of powerful consumer-branded mobile devices has resulted
in employees in wanting to use smartphones or tablets at work and home to share files and data,
regardless of time of day. This raises security and privacy issues. According to a recent study
titled “The Risk of Regulated Data on Mobile Devices” by Ponemon Institute many companies
are not taking the necessary steps to protect sensitive data on mobile devices. Fifty-four percent
of respondents in the study had on average five data breach events, from either theft or loss of
mobile devices that held regulated, sensitive data (Ponemon Institute, 2013).
Given this situation, small organizations that utilize cloud computing, like the participants in this
case study, should develop a mobile device security program that builds on existing network
security and Mobile Device Management (MDM) system, which can help address a variety of
mobile security concerns, using the following recommendations:
Research The Mobile Threatscape. Considering Google Android and Apple iOS are dominant
consumer platforms and BYOD has compelling advantages for business, comparison of these
operating systems would be necessary. According to the Ponemon study 59 percent of
organizations allow their employees to use their personally owned mobile devices (BYOD) at
work, as seen in Figure 1 below (Ponemon Institute, 2013).
Figure 1: Percentage of employees using personally owned mobile devices in the workplace
(Ponemon Institute, 2013).
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Reisinger (2012) noted that the overall security of Android devices is a major threat and most
security experts now view Android as the most attacked mobile OS, the easiest to target because
of its open architecture. According to Juniper Networks "2011 Internet Security Threat
Intelligence Report" (Juniper, 2012) more than 25 times more Android Malware was identified
in 2011 than in 2010. In fact in 2011 alone, malware targeting of the Google's Android platform
rose 3,325 percent, Figure 2 below (Juniper Networks, 2012).
Figure 2: Cumulative Android Malware Increase in 2011. (Juniper Networks, 2012).

Develop a Mobile Device Security Plan. Using a written plan, organizations should clearly
indicate how company and personal mobile devices are allowed to connect to corporate
resources, with defined levels of permitted access. An MDM system (discussed below) should
be deployed to secure, monitor, manage and support all mobile devices that connect to company
resources. The organization's mobile risks, regulatory compliance issues, and governance issues
should be identified, and appropriate security and access controls that should be in
place. Document backups and disaster recovery plans, as well as remote wiping procedures, and
mobile applications policies should be developed. End-users should be trained, based on device
and/or operating systems as well as the acceptable use policies of the organization.
Deploy Mobile Device Management (MDM) system. This software secures, monitors, manages
and supports all mobile devices on multiple operating systems. It usually includes over-the-air
distribution of applications, data and configuration settings for all types of mobile devices. It can
be made applicable to both company-owned and personal devices. An MDM system can also
deploy and manage third-party or in-house mobile applications.
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Create Centralized Network Access Control for Mobile Devices. Develop mobile authentication
practices that provide endpoint integrity checks and authorization of resources, e.g. VPN via
Cisco IPSec, SSL VPN, SSL/TLS with X.509 certificates, WPA2 Enterprise with 802.1X,
certificate-based authentication, and RSA SecurID or CRYPTOCard.
Mobile Device Authentication Policy. Establish strong device security policies to protect
corporate information, e.g. strong passcodes, passcode expirations, passcode reuse history,
maximum failed attempts, over-the-air passcode enforcement, progressive passcode timeout, etc.
Mobile Device Configuration and Restrictions. Devices should be configured using MDM
systems with encrypted configuration profiles, e.g. CMS (Cryptographic Message Syntax)
supporting 3DES and AES 128. Device restrictions determine which features users can access
on the device, like passcode policies, cameras, or web-browsing restrictions.
Mobile Data security. Devices should include hardware encryption (like 256-bit AES) and data
protection (unique device passcodes) to generate strong encryption keys. Additionally, remote
wipe and local wipe features set by an MDM server are important.
Mobile Application Security. Ensure runtime protection so that applications are “sandboxed”
and cannot access data stored by other applications. Mandatory code signing - third-party
applications that are signed by the developer using certificates issued by a device manufacturer,
e.g. Google or Apple. Application encryption APIs that allow software developers to
symmetrically encrypt data using, for example, AES or 3DES.
Regulatory Proficiency
Every organization in this study was required to comply with various regulatory agencies and
auditors, both inside and outside the United States. The cloud systems used by these types of
organizations present ongoing regulatory challenges, which have very high audit and data
retention requirements. Despite the challenges, cloud computing can provide these organizations
with regulatory compliance mechanisms that are scalable and available on-demand. This can be
accomplished by performing a gap analysis and then mapping the chosen cloud service model to
security controls and necessary compliance models. This process is illustrated in Figure 3.
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Figure 3: Mapping Cloud Model to Security Controls & Compliance Models (Cloud
Security Alliance, 2011).

Improved Reliability and Access
Another major concern of organizations in this case study was the reliability of their key
systems. Organizations preferred “high availability” (HA) cloud systems that provided
"99.999%" availability of services (downtime less than 5.26 minutes per year). In order to
achieve HA reliability organizations should design or require CSPs to provide: replicated servers
across multiple zones, automatic failover or mirroring, and comprehensive disaster recovery.
CONCLUSIONS
Cloud adoption is poised to grow in the future. According to Gardner Research, by 2016 at least
50 percent of enterprise email users will rely primarily on a web browser, mobile tablet or
mobile device instead of a desktop client. Gartner Research also predicts that by 2017 more
than 50 percent of Global 1000 companies will store customer-sensitive data in the public cloud
(Gartner Research, 2008; Savitz, 2011). Mullin (2009) notes drug companies like Pfizer, Eli
Lilly & Co., Johnson & Johnson, and Genentech that have adopted cloud computing found
benefits with large amounts of data storage, lower costs, and faster data processing. The
companies in this study indicated they plan to continue using various types of cloud computing.
The main objective of our study was to examine the various aspects of cloud computing
implementation as it relates to emerging life-sciences companies. We hoped to identify the
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unique benefits, drawbacks, and various drivers of cloud implementation in these companies.
Interpretations from this research indicate that small life-sciences companies found cloud
computing very attractive in general. There were some relatively minor drawbacks, which could
be mitigated with adequate planning and proper implementation.
Our study identified many common themes apparent in the companies that were studied. The
advantages of cloud computing in the emerging biotech and pharmaceutical organizations
studied were identified as: reduced cost and greater R&D speed, improved efficiency, enhanced
agility, superior storage and data analysis, improved change management, superior collaboration
and connectivity, enhanced security, faster drug discovery, better performance, appreciable
regulatory proficiency, and much greater scalability and flexibility of IT resources. The study
challenges of cloud computing in the emerging biotech and pharmaceutical organizations, as
evident from the organizations studied were: concerns about security, confidentiality of
corporate data, legal ramifications, cloud vendor lock-in, and lack of information systems
control.
Security concerns and regulatory issues were identified as the predominant challenges of cloud
computing in this study. However, with limited budgets and few, if any, onsite security
professionals, the SMB life-science companies in this study considered the overall security and
control features provided by CSPs as superior and more comprehensive than what could be
achieved by their limited in-house staff. There would be cost efficiencies as well. However, it is
clear that as cloud computing grows, CSPs must maintain the highest levels of security in order
to retain this advantage and true business value for these organizations. The CSPs helped the
companies satisfy their regulatory challenges. Regarding the regulatory aspect of cloud
computing, the scenario is bleaker. Participants pointed out that a lack of clear-cut regulations
regarding cloud computing from the regulatory agencies was a disincentive to further cloud
adoption.
Companies in this study initially lacked the adequate computational infrastructure to meet their
future needs. In order to gain such abilities they often partnered with larger academic
institutions, biotech, or pharmaceutical companies. The participants and organizations in this
study seemed to be ideal candidates for larger-scale participation in cloud computing. Those
organizations that have embraced cloud computing were able to efficiently grow and more
quickly build competitive advantages, while simultaneously reducing IT expenditures – no
longer having to procure, maintain, and update systems or support all end-users.
Smaller organizations that lacked adequate computational or data management infrastructure
were ideally poised to take advantage of cloud computing's pay-as-you-grow structure. The
organizations in this study found cloud computing met their needs for voluminous internal
computer power without additional IT overhead. The study also found that cloud computing
offered a major business advantage to SMB life sciences companies – with its faster, cheaper,
more scalable model – thereby helping these companies create a competitive parity with much
larger organizations and at least a competitive advantage over their peers.
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FUTURE WORK
In the future, this research could be expanded to include significantly more participants and
organizations of different types, beyond just life science companies and their business processes.
That would help determine and uncover additional opportunities or challenges that cloud
computing would pose to organizations. This research could also be extended to involve
significantly more participants and companies to perhaps reveal comprehensive cloud taxonomy
or enterprise architecture for other types of emerging organizations.
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APPENDIX
Figure A-1: Survey Questions and Interview Protocol.
1)

What is your strategic role within your organization?

2)

What are the reasons behind your organization's use of Cloud Computing?

3)

Which service model does your organization currently utilize, based on this Cloud Computing
taxonomy
Which deployment model does your organization currently utilize, based on this Cloud
Computing taxonomy?
Who currently hosts and manages your cloud computing environment?

4)
5)
6)
7)

Which IT services or applications, that support your business processes, have/would you
migrate to Cloud Computing?
Are you or would you be willing to outsource to multiple cloud computing providers?

8)

In your assessment of the feasibility and profitability of your cloud computing environment,
what are the biggest advantages?
9) In your assessment of the feasibility and profitability of your cloud computing environment,
what are the biggest disadvantages?
10) What are your main concerns regarding your organization's approach to Cloud Computing?
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Figure A-2: OpenID Connect Protocol Suite.
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